Skip to main content
. 2018 Jun 29;11:113–119. doi: 10.2147/PGPM.S160763

Figure 4.

Figure 4

(A) Dynamics of changes in the UKU scale scores across patients with different genotypes of CYP2D6 gene by polymorphic marker 1846G>A on days 5 to 14 of the inpatient treatment course (data are presented as Me and IQR). (B) Dynamics of changes in the UKU scale scores across patients with different genotypes of CYP2D6 gene by polymorphic marker 1846G>A on days 14 to 21 of the inpatient treatment course (data are presented as Me and IQR).

Abbreviations: IQR, interquartile rage; Me, median; UKU, The UKU Side Effect Rating Scale.